Comparative irritation potential of two combination acne products: A randomized controlled, subject- and evaluator-blind, comparative study in healthy volunteers

American Journal of Clinical Dermatology

Volumn 9, Issue 5, 2008, Pages 313-317

  Dosik, Jonathan S ^a   Vamvakias, George ^b  

^a TKL RESEARCH INC   (United States)

^b Global Health Outcomes and Market Access   (United States)

Author keywords

Acne, treatment; Benzoyl peroxide, therapeutic use; Clindamycin, therapeutic use

Indexed keywords

ANTI ACNE AGENT; BENZACLIN; BENZOYL PEROXIDE PLUS CLINDAMYCIN; DODECYL SULFATE SODIUM; DUAC; IRRITANT AGENT; UNCLASSIFIED DRUG; WHITE PETROLATUM;

ACNE VULGARIS; ADULT; ARTICLE; CAUCASIAN; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDERMIS CELL; ERYTHEMA; FEMALE; HUMAN; MALE; NORMAL HUMAN; PATCH TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN; SKIN EDEMA; SKIN IRRITATION; SKIN MANIFESTATION; VOLUNTEER;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANALYSIS OF VARIANCE; BENZOYL PEROXIDE; CLINDAMYCIN; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS;

EID: 50049122409     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200809050-00005     Document Type: Article

References (15)

1. Goodman G. Acne and acne scarring: the case for active and early intervention. Aust Fam Physician 2006; 35: 503-4
2. Hanna S, Sharma J, Klotz J. Acne vulgaris: more than skin deep. Dermatol Online J 2003; 9: 8
3. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997; 37: 590-5
4. Dermik Laboratories. BenzaClin® [package insert]. Bridgewater (NJ): Dermik Laboratories, 2007
5. Stiefel Laboratories. Duac® [package insert]. Coral Gables (FL): Stiefel Laboratories, 2007
6. Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651-63
7. Fagundes DS, Fraser JM, Klauda HC. Differences in the irritation potential and cosmetic acceptability of two combination topical acne gels: combined results of two comparative studies. Todays Ther Trends 2003; 21: 269-75
8. Del Rosso JQ. The role of the vehicle in combination acne therapy. Cutis 2005; 76 (2 Suppl.): 15-8
9. Tanghetti EA, Gold MH, Fraser JM. A two-center patient preference study comparing two benzoyl peroxide/clindamycin gels in acne vulgaris patients [abstract no. P108]. J Am Acad Dermatol 2005; 52 (3 Suppl.): P12
10. Ellis CN, Leyden J, Katz HI, et al. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris. Cutis 2001; 67 (2 Suppl.): 13-20
11. Tschen EH, Katz HI, Jones TM, et al. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis 2001; 67: 165-9
12. Zhen Y, Stoudemayer M, Vamvakias G, et al. Pilot investigation of the hydrating effects of topical acne medications. J Drugs Dermatol 2007; 6: 810-6
13. Dosik JS, Gilbert RD, Arsonnaud S. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies. Skinmed 2006; 5: 219-23
14. Center for Drug Evaluation and Research (CDER). Guidance for industry: skin irritation and sensitization testing of generic transdermal drug products. U.S. Dept of Health and Human Services, Food and Drug Administration [online]. Available from URL: http://www.fda.gov/cder/guidance/2887fnl.htm [Accessed 2008 Jul 28]
15. Brand B, Gilbert R, Baker MD, et al. Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents. J Am Acad Dermatol 2003; 49 (3 Suppl.): S227-32